These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 16179760

  • 1. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems.
    Saupe A, Wissing SA, Lenk A, Schmidt C, Müller RH.
    Biomed Mater Eng; 2005; 15(5):393-402. PubMed ID: 16179760
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nanostructured lipid carriers as novel carrier for sunscreen formulations.
    Xia Q, Saupe A, Müller RH, Souto EB.
    Int J Cosmet Sci; 2007 Dec; 29(6):473-82. PubMed ID: 18489386
    [Abstract] [Full Text] [Related]

  • 5. Characterization of indomethacin-loaded lipid nanoparticles by differential scanning calorimetry.
    Castelli F, Puglia C, Sarpietro MG, Rizza L, Bonina F.
    Int J Pharm; 2005 Nov 04; 304(1-2):231-8. PubMed ID: 16188405
    [Abstract] [Full Text] [Related]

  • 6. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
    Kovacevic A, Savic S, Vuleta G, Müller RH, Keck CM.
    Int J Pharm; 2011 Mar 15; 406(1-2):163-72. PubMed ID: 21219990
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
    Fang JY, Fang CL, Liu CH, Su YH.
    Eur J Pharm Biopharm; 2008 Oct 15; 70(2):633-40. PubMed ID: 18577447
    [Abstract] [Full Text] [Related]

  • 9. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
    Attama AA, Müller-Goymann CC.
    Int J Pharm; 2007 Apr 04; 334(1-2):179-89. PubMed ID: 17140752
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Solid lipid nanoparticles for parenteral drug delivery.
    Wissing SA, Kayser O, Müller RH.
    Adv Drug Deliv Rev; 2004 May 07; 56(9):1257-72. PubMed ID: 15109768
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Chemical stability of lipid excipients in SLN-production of test formulations, characterisation and short-term stability.
    Radomska-Soukharev A, Müller RH.
    Pharmazie; 2006 May 07; 61(5):425-30. PubMed ID: 16724540
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
    Zhao XL, Yang CR, Yang KL, Li KX, Hu HY, Chen DW.
    Drug Dev Ind Pharm; 2010 Jul 07; 36(7):773-80. PubMed ID: 20136496
    [Abstract] [Full Text] [Related]

  • 18. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for application of ascorbyl palmitate.
    Uner M, Wissing SA, Yener G, Müller RH.
    Pharmazie; 2005 Aug 07; 60(8):577-82. PubMed ID: 16124399
    [Abstract] [Full Text] [Related]

  • 19. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA, Schicke BC, Paepenmüller T, Müller-Goymann CC.
    Eur J Pharm Biopharm; 2007 Aug 07; 67(1):48-57. PubMed ID: 17276663
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.